BPS 2110 - FINAL EXAM UPDATED ACTUAL
QUESTIONS AND CORRECT ANSWERS
Question:
1. What is the goal of Phase 1 of Clinical Trials?
Answer:
Dose Finding
Question:
2. How many patients are involved in Phase 1 of Clinical
Trials?
Answer:
Small number (<100)
Question:
3. What type of patients are involved in Phase 1 of Clinical
Trials?
Answer:
Healthy volunteers
Question:
4. What is the average time taken for Phase 1 of Clinical
Trials?
Answer:
< 1 year
Question:
5. What is the drug failure rate of Phase 1 of Clinical Trials?
Answer:
30%
Question:
6. What is the goal of Phase 2 of Clinical Trials?
Answer:
Safety and efficacy
,Question:
7. How many patients are involved in Phase 2 of Clinical
Trials?
Answer:
Medium number (~200-300)
Question:
8. What type of patients are involved in Phase 2 of Clinical
Trials?
Answer:
Patients
Question:
9. What is the average time taken for Phase 2 of Clinical
Trials?
Answer:
~1 year
Question:
10. What is the drug failure rate of Phase 2 of Clinical Trials?
Answer:
~70%
Question:
11. What is the goal of Phase 3 of Clinical Trials?
Answer:
Find rare side effects
Question:
12. How many patients are involved in Phase 3 of Clinical
Trials?
Answer:
Large number (~1000)
Question:
13. What is the average time taken for Phase 3 of Clinical
Trials?
Answer:
~1 year
, Question:
14. What type of patients are involved in Phase 3 of Clinical
Trials?
Answer:
Patients
Question:
15. What is the drug failure rate of Phase 3 of Clinical Trials?
Answer:
~70%
Question:
16. What are the two general types of large pharmaceutical
companies?
Answer:
Ethical pharmaceutical companies and generic pharmaceutical companies
Question:
17. What are ethical pharmaceutical companies?
Answer:
Companies that invest heavily in research. They discover and develop new
molecular entities.
Question:
18. What are generic pharmaceutical companies?
Answer:
They focus on breaking/ adapting patents and manufacturing methods and
formulation.
Question:
19. What are drug products?
Answer:
Licensed products that contain the same molecular entities in different forms.
Question:
20. What are molecular entities?
Answer:
The active ingredient in drugs.
QUESTIONS AND CORRECT ANSWERS
Question:
1. What is the goal of Phase 1 of Clinical Trials?
Answer:
Dose Finding
Question:
2. How many patients are involved in Phase 1 of Clinical
Trials?
Answer:
Small number (<100)
Question:
3. What type of patients are involved in Phase 1 of Clinical
Trials?
Answer:
Healthy volunteers
Question:
4. What is the average time taken for Phase 1 of Clinical
Trials?
Answer:
< 1 year
Question:
5. What is the drug failure rate of Phase 1 of Clinical Trials?
Answer:
30%
Question:
6. What is the goal of Phase 2 of Clinical Trials?
Answer:
Safety and efficacy
,Question:
7. How many patients are involved in Phase 2 of Clinical
Trials?
Answer:
Medium number (~200-300)
Question:
8. What type of patients are involved in Phase 2 of Clinical
Trials?
Answer:
Patients
Question:
9. What is the average time taken for Phase 2 of Clinical
Trials?
Answer:
~1 year
Question:
10. What is the drug failure rate of Phase 2 of Clinical Trials?
Answer:
~70%
Question:
11. What is the goal of Phase 3 of Clinical Trials?
Answer:
Find rare side effects
Question:
12. How many patients are involved in Phase 3 of Clinical
Trials?
Answer:
Large number (~1000)
Question:
13. What is the average time taken for Phase 3 of Clinical
Trials?
Answer:
~1 year
, Question:
14. What type of patients are involved in Phase 3 of Clinical
Trials?
Answer:
Patients
Question:
15. What is the drug failure rate of Phase 3 of Clinical Trials?
Answer:
~70%
Question:
16. What are the two general types of large pharmaceutical
companies?
Answer:
Ethical pharmaceutical companies and generic pharmaceutical companies
Question:
17. What are ethical pharmaceutical companies?
Answer:
Companies that invest heavily in research. They discover and develop new
molecular entities.
Question:
18. What are generic pharmaceutical companies?
Answer:
They focus on breaking/ adapting patents and manufacturing methods and
formulation.
Question:
19. What are drug products?
Answer:
Licensed products that contain the same molecular entities in different forms.
Question:
20. What are molecular entities?
Answer:
The active ingredient in drugs.